Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02887781

Acronym

TSAR

Enrollment

150

Registered

2016-09-02

Start date

2015-08-13

Completion date

2024-12-31

Last updated

2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberous Sclerosis Complex

Brief summary

This study aims to investigate the factors (clinical, care-related and genetic) affecting renal outcome in patients with TSC (Tuberous sclerosis complex)

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

8 Years to No maximum

Healthy volunteers

Inclusion criteria

of study participants * Patient presenting with an isolated angiomyolipoma or * Patient presenting with tuberous sclerosis complex combined with an angiomyolipoma or * Patient presenting with tuberous sclerosis complex * Patient not objecting to the study

Exclusion criteria

of study participants ■Patient objecting to the study

Design outcomes

Primary

Measure	Time frame
Evolution of the renal function estimated by the MDRD GFR	18 months after inclusion

Countries

France

Contacts

Primary ContactYannick LE MEUR, MD PhD

yannick.lemeur@chu-brest.fr

Outcome results